Intranasal oxytocin in the treatment of schizophrenia

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2014
INTERVENTION: Oxytocin was dosed at 24 IU twice a day for 12 weeks. CONDITION: Schizophrenia PRIMARY OUTCOME: The change of clinical symptoms calculated by the PANSS. SECONDARY OUTCOME: The change of social cognition and the body weight. INCLUSION CRITERIA: The chronic schizphrenia patients whose body mass index was over 25.
Epistemonikos ID: 5d8bade9640a17328b7ab7b914869ef73188f09f
First added on: Aug 22, 2024